Sanofi (SNY)
Add to Watchlists Create an Alert
54.56
-0.49 -0.89%
NYSE
May 23, 8:00PM
BATS Real time
Currency in USD
Sanofi Revenue Quarterly:
10.45B for March 31, 2013Sanofi Historical Revenue Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 10.45B |
| Dec. 31, 2012 | 11.48B |
| Sept. 30, 2012 | 11.93B |
| June 30, 2012 | 11.34B |
| March 31, 2012 | 11.90B |
| Dec. 31, 2011 | 11.56B |
| Sept. 30, 2011 | 12.42B |
| June 30, 2011 | 12.59B |
| March 31, 2011 | 11.56B |
| Dec. 31, 2010 | 12.97B |
| Sept. 30, 2010 | 11.21B |
| June 30, 2010 | 11.26B |
| March 31, 2010 | 10.44B |
| Dec. 31, 2009 | 11.08B |
| Sept. 30, 2009 | 11.34B |
| June 30, 2009 | 10.98B |
| March 31, 2009 | 9.825B |
| Dec. 31, 2008 | 10.54B |
| Sept. 30, 2008 | 10.31B |
| June 30, 2008 | 11.22B |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.
While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More
SNY Revenue Quarterly Benchmarks
| Companies | |
|---|---|
| AstraZeneca | 6.385B |
| Novartis | 14.21B |
| Eli Lilly and Company | 5.602B |
SNY Revenue Quarterly Rankings
| Overall |
98th percentile 124 of 8009 |
| Sector |
98th percentile 12 of 687 in Healthcare |
| Industry |
90th percentile 5 of 55 in Drug Manufacturers - Major |
SNY Revenue Quarterly Range, Past 5 Years
| Minimum | 9.825B | Mar 2009 |
| Maximum | 12.97B | Dec 2010 |
| Average | 11.32B |